Personalis Q4 revenue $19.7M (+18% YoY); FY2024 revenue guidance $73-75M

Personalis, Inc.

2023-FY EPS reported -$2.25 revenue$73,481,000

Q4 2023 revenue $19.7M (+18% YoY); FY2023 revenue $73.5M (+13% YoY).
Q4 net loss $26.6M ($0.54 EPS); FY net loss $108.3M ($2.25 EPS).
FY2024 guidance: revenue $73-75M, net loss ~$80M (down from $108.3M), cash usage ~$62M.
Obtained final Medicare coverage for NeXT Dx tumor profiling test; partnerships with Tempus, Myriad, ClearNote, and Natera extension.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Personalis, Inc. reported financial results for the fourth quarter ended December 31, 2023.

Period: the fourth quarter ended December 31, 2023
Result: reported results

Exact text from the filing

Personalis, Inc. issued a press release announcing its financial results for the quarter and fiscal year ended December 31, 2023

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Personalis, Inc. reported financial results for the full year ended December 31, 2023.

Period: the full year ended December 31, 2023
Result: reported results

Exact text from the filing

Personalis, Inc. issued a press release announcing its financial results for the quarter and fiscal year ended December 31, 2023

View on SEC.gov

708 earnings releases filed in the last 30 days. Browse all earnings releases →

Personalis, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-022032

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.